3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Stress Disorders, Post-Traumatic
1
Sleep Initiation and Maintenance Disorders
1
Sleep Disorders, Circadian Rhythm
1
Sleep Deprivation
1
REM Sleep Behavior Disorder
1
Psychological Well-Being
1
Pain
1
Leukemia
1
Idiopathic Hypersomnia
1
Depression
1
Combat Disorders
1
Chronobiology Disorders
1
Cancer Pain
1
Anxiety Disorders
1
Alzheimer Disease
1
Interventions
Fentanyl
13
Zoledronic Acid
8
Ibandronic Acid
8
nabiximols
6
Oxycodone
6
Tapentadol
5
Morphine
4
Hydromorphone
4
Cryotherapy
4
Cryosurgery
4
alvimopan
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
resiniferatoxin
2
cabozantinib
2
Tetrodotoxin
2
Radiation
2
Prednisone
2
Naloxone
2
Diclofenac
2
Analgesics, Opioid
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
ziconotide
1
oxycodone naloxone combination
1
imisopasem manganese
1
fulranumab
1
Xylitol
1
Ultracet
1
Transdermal Patch
1
Therapeutics
1
Sufentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Pain
×
Propofol
×
Clear all
NCT06644573
2025-05-28
PSHW
PROSOMNIA Sleep Health & Wellness
Phase 1
Not yet recruiting
100 enrolled